Clinical Trial Update: Proton Therapy With Capecitabine for Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

The trial evaluating capecitabine with proton therapy for rectal cancer has been withdrawn (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Rectal Cancer | Phase 1, Phase 2 | Status: WITHDRAWN